Integrated proteomic, transcriptomic, and epigenomic profiling identifies SRA1 as a novel therapeutic target for postpartum depression

Researchers have identified the SRA1 gene as a potential therapeutic target for postpartum depression using an integrated multi-omics analysis. The study suggests that SRA1 expression and its methylation levels are significantly linked to the risk of developing the condition.